Difference between revisions of "TC99m Biomarker Committee"

From QIBA Wiki
Jump to: navigation, search
m (Recent Meetings/Call Summaries)
m (Recent Meetings/Call Summaries)
 
Line 9: Line 9:
 
==Recent Meetings/Call Summaries==
 
==Recent Meetings/Call Summaries==
  
 +
*[[Media:2020_02-11_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | February 11, 2020]]
 +
 +
Break during Profile Public Comment period
 
*[[Media:2019_10-08_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | October 8, 2019]]
 
*[[Media:2019_10-08_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | October 8, 2019]]
 
*[[Media:2019_09-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | September 10, 2019]]
 
*[[Media:2019_09-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | September 10, 2019]]

Latest revision as of 21:52, 12 February 2020

Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
RSNA Staff Support: Julie Lisiecki


Full name of biomarker committee: Technetium-99m for body, oncology, and immunology

Recent Meetings/Call Summaries

Break during Profile Public Comment period

SPECT TC99m BC Call Summaries Archive

Profile Development

Reference Materials